UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors

Scientific reports, 2021-06, Vol.11 (1), p.12303-12303, Article 12303

2021

Volltextzugriff (PDF)

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

BMC cancer, 2022-03, Vol.22 (1), p.256-21, Article 256

2022

Volltextzugriff (PDF)

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Journal of patient-reported outcomes, 2021-09, Vol.5 (1), p.82-82, Article 82

2021

Volltextzugriff (PDF)

APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes

Cancers, 2021-10, Vol.13 (21), p.5394

2021

Volltextzugriff (PDF)

Serum Survivin in Oral Submucosal Fibrosis and Squamous Cell Carcinoma

Indian journal of otolaryngology, and head, and neck surgery, 2022-10, Vol.74 (Suppl 2), p.2027-2032

2022

Volltextzugriff (PDF)

Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer

Cancers, 2022-03, Vol.14 (6), p.1451

2022

Volltextzugriff (PDF)

Patterns of chemotherapy‐associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study

Cancer medicine (Malden, MA), 2014-04, Vol.3 (2), p.434-444

2014

Volltextzugriff (PDF)

Estimation of Serum Levels of Heavy Metals in Patients with Chronic Invasive Fungal Rhinosinusitis Before the COVID-19 Era: A Pilot Study

Turkish archives of otolaryngology, 2022-03, Vol.60 (1), p.29-35

2022

Volltextzugriff (PDF)

Treatment Patterns and Survival in Locally Advanced or Metastatic Biliary Tract Cancer Using SEER Medicare Data

Gastro hep advances, 2023, Vol.2 (4), p.580-587

2023

Volltextzugriff (PDF)

Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population

Journal of palliative medicine, 2011-11, Vol.14 (11), p.1231-1235

2011

Volltextzugriff (PDF)

ICA pseudoaneurysms and fistulas presenting as severe epistaxis: Endovascular management

Interdisciplinary neurosurgery : Advanced techniques and case management, 2020-12, Vol.22, p.100818, Article 100818

2020

Volltextzugriff (PDF)

Comparison between early and delayed facial nerve decompression in traumatic facial nerve paralysis - A retrospective study

CoDAS (São Paulo), 2018-01, Vol.30 (1)

2018

Volltextzugriff (PDF)

Tele-chemotherapy and related outcomes to improve rural cancer care

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.142-142

2022

Volltextzugriff (PDF)

Reproductive and fertility-related challenges in female patients diagnosed with early-onset colorectal cancer

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.57-57

2024

Volltextzugriff (PDF)

Treatment of metastatic pancreatic adenocarcinoma: a review

Oncology (Williston Park, N.Y.), 2014-01, Vol.28 (1), p.70

2014

Volltextzugriff (PDF)

Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2016-08, Vol.22 (8), p.1368-1375

2016

Volltextzugriff (PDF)

Could the PD-1 pathway be a potential target for treating small intestinal adenocarcinoma?

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.233-233

2016

Volltextzugriff (PDF)

Feasibility of tele-chemotherapy administration to improve access to rural cancer patients

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.112-112

2021

Volltextzugriff (PDF)

APC and TP53 as potential biomarkers for EGFR sensitivity in colorectal cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4094-4094

2020

Volltextzugriff (PDF)

A phase 1, open-label, dose escalation and expansion, multicenter study of claudin 18.2-targeted chimeric antigen receptor T-cells in patients with unresectable, locally advanced, or metastatic gastric, gastroesophageal junction, esophageal, or pancreatic adenocarcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS480-TPS480

2023

Volltextzugriff (PDF)

Integrated supportive oncology program and outcomes for cancer patients at the end of life

JCO oncology practice, 2023-11, Vol.19 (11_suppl), p.240-240

2023

Volltextzugriff (PDF)

APC as a high-utility mutational biomarker that may identify subpopulations of patients with mutant RAS/BRAF and right-sided colorectal cancer (CRC) who derive benefit from EGFR inhibitors (EGFRi)

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.56-56

2024

Volltextzugriff (PDF)

High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or tumor sidedness

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.203-203

2024

Volltextzugriff (PDF)

Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?

American journal of clinical pathology, 2017-09, Vol.148 (3), p.208-214

2017

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes

Serum Survivin in Oral Submucosal Fibrosis and Squamous Cell Carcinoma

Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer

Patterns of chemotherapy‐associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study

Estimation of Serum Levels of Heavy Metals in Patients with Chronic Invasive Fungal Rhinosinusitis Before the COVID-19 Era: A Pilot Study

Treatment Patterns and Survival in Locally Advanced or Metastatic Biliary Tract Cancer Using SEER Medicare Data

Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population

ICA pseudoaneurysms and fistulas presenting as severe epistaxis: Endovascular management

Comparison between early and delayed facial nerve decompression in traumatic facial nerve paralysis - A retrospective study

Tele-chemotherapy and related outcomes to improve rural cancer care

Reproductive and fertility-related challenges in female patients diagnosed with early-onset colorectal cancer

Treatment of metastatic pancreatic adenocarcinoma: a review

Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation

Could the PD-1 pathway be a potential target for treating small intestinal adenocarcinoma?

Feasibility of tele-chemotherapy administration to improve access to rural cancer patients

APC and TP53 as potential biomarkers for EGFR sensitivity in colorectal cancer

A phase 1, open-label, dose escalation and expansion, multicenter study of claudin 18.2-targeted chimeric antigen receptor T-cells in patients with unresectable, locally advanced, or metastatic gastric, gastroesophageal junction, esophageal, or pancreatic adenocarcinoma

Integrated supportive oncology program and outcomes for cancer patients at the end of life

APC as a high-utility mutational biomarker that may identify subpopulations of patients with mutant RAS/BRAF and right-sided colorectal cancer (CRC) who derive benefit from EGFR inhibitors (EGFRi)

High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or tumor sidedness

Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?

Suchergebnisse filtern